Prognostic role of chromosomal translocations (CT) in myelodysplasia (MDS) was retrospectively analyzed in 77 patients from GROM-L registry. Forty (51.9%) balanced, 28 (36.4%) unbalanced and 9 (11.7%) concomitant balanced and unbalanced CT were identified. Five-year overall survival (OS) of the entire cohort was 34.5% (CI 95% 22.546.5). Five-year OS of patients with unbalanced CT was significantly shorter than that of patients carrying balanced CT [22.3% (CI 95% 4.040.6) vs 44.0% (CI 95% 26.761.3) (p¼0.042)]. Five-year OS of patients with CT included in complex karyotype (CK) was significantly shorter than that of patients with isolated CT or CT with another abnormality [5.5% (CI 95% 015.7) vs 42.9% (CI 95% 21.364.5) and vs 4% (CI 95% 31.679.2) (p<0.001)]. Presence of CT in MDS characterizes a more aggressive outcome only when associated with CK.

5. Balanced and Unbalanced Chromosomal Translocatios in Myelodysplastic Syndromes: Clinical and Prognostic Signficance / Mohamed, S.; Latagliata, R.; Limongi, M. Z.; Nigro, S.; Sangiorgi, E.; Nanni, M.; Piccioni, A.; Campagna, A.; Aloe Spiriti, M. A.; Carmosino, I.; Molica, M.; Mariggiò, E.; Rosati, S.; Colafigli, G.; Fazio, F.; De Luca, M. L.; De Benedittis, D.; Scalzulli, E.; Breccia, M.; Mancini, M.. - In: LEUKEMIA & LYMPHOMA. - ISSN 1042-8194. - (2020).

5. Balanced and Unbalanced Chromosomal Translocatios in Myelodysplastic Syndromes: Clinical and Prognostic Signficance.

F. Fazio;M. Breccia;
2020

Abstract

Prognostic role of chromosomal translocations (CT) in myelodysplasia (MDS) was retrospectively analyzed in 77 patients from GROM-L registry. Forty (51.9%) balanced, 28 (36.4%) unbalanced and 9 (11.7%) concomitant balanced and unbalanced CT were identified. Five-year overall survival (OS) of the entire cohort was 34.5% (CI 95% 22.546.5). Five-year OS of patients with unbalanced CT was significantly shorter than that of patients carrying balanced CT [22.3% (CI 95% 4.040.6) vs 44.0% (CI 95% 26.761.3) (p¼0.042)]. Five-year OS of patients with CT included in complex karyotype (CK) was significantly shorter than that of patients with isolated CT or CT with another abnormality [5.5% (CI 95% 015.7) vs 42.9% (CI 95% 21.364.5) and vs 4% (CI 95% 31.679.2) (p<0.001)]. Presence of CT in MDS characterizes a more aggressive outcome only when associated with CK.
2020
Myelodysplastic syndromes; karyotype; chromosomal translocations; prognosis
01 Pubblicazione su rivista::01a Articolo in rivista
5. Balanced and Unbalanced Chromosomal Translocatios in Myelodysplastic Syndromes: Clinical and Prognostic Signficance / Mohamed, S.; Latagliata, R.; Limongi, M. Z.; Nigro, S.; Sangiorgi, E.; Nanni, M.; Piccioni, A.; Campagna, A.; Aloe Spiriti, M. A.; Carmosino, I.; Molica, M.; Mariggiò, E.; Rosati, S.; Colafigli, G.; Fazio, F.; De Luca, M. L.; De Benedittis, D.; Scalzulli, E.; Breccia, M.; Mancini, M.. - In: LEUKEMIA & LYMPHOMA. - ISSN 1042-8194. - (2020).
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1497671
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact